Covid cases surged during the last two winters and are likely to again this year — unless the country can prepare and act, White House Covid-19 response coordinator Ashish Jha said Sunday morning. “If we don’t get ahead of this thing, we’ll have a lot of waning immunity, this virus continues to evolve and we ...
Prescription drug rebates from drugmakers to commercial health plans are steadily increasing, a study published in JAMA Health Forum shows. Why it matters: This is all part of a system in which drugmakers negotiate to get their product on the formularies of middlemen known as pharmacy benefit managers and health plans. * “While drug rebates can reduce plans’ net costs, ...
An estimated 30 million people did not have insurance coverage last year, bringing the uninsured rate to 9.2%—only slightly below the major high of 9.7% from 2020, new federal data show. The National Center for Health Statistics released its latest report Thursday on estimates for health insurance coverage last year. The data showed slight gains ...
The latest batch of hospital patient safety ratings from the Leapfrog Group shows a general decline among “several” hospital safety measures concurrent with the onset of the COVID-19 pandemic, according to the healthcare safety watchdog. Released Tuesday, the scores are accompanied by a report from Leapfrog that highlights a “significant” decline in the experiences of ...
Between 5.3 million and 14.2 million enrollees could lose Medicaid coverage next year as the Biden administration is expected to roll back the program’s continuous coverage provision, a new analysis finds. The analysis, released Tuesday by the Kaiser Family Foundation, explores how much enrollment in Medicaid changed during the pandemic, including the impact of a ...
As an increasing number of pharma manufacturers enact new restrictions on 340B drug discounts, hospitals participating in the program have now more than doubled the annual loss projections they gave at the tail-end of 2021, industry group 340B Health writes in a new report. During a December 2021 survey when eight drugmakers had announced restrictions, critical access ...